The recent discovery of glycine transporters in both the central nervous sy
stem and the periphery suggests that glycine transport may be critical to N
-methyl-D-aspartate receptor (NMDAR) function by controlling glycine concen
tration at the NMDAR modulatory glycine site. Data obtained from whole-cell
patch-clamp recordings of hippocampal pyramidal neurons, in vitro, demonst
rated that exogenous glycine and glycine transporter type 1 (GLYT1) antagon
ist selectively enhanced the amplitude of the NMDA component of a glutamate
rgic excitatory postsynaptic current. The effect was blocked by 2-amino-5-p
hosphonovaleric acid and 7-chloro-kynurenic acid but not by strychnine, Thu
s, the glycine-binding site was not saturated under the control conditions.
Furthermore, GLYT1 antagonist enhanced NMDAR function during perfusion wit
h medium containing 10 mu M glycine, a concentration similar to that in the
cerebrospinal fluid in vivo, thereby supporting the hypothesis that the GL
YT1 maintains subsaturating concentration of glycine at synaptically activa
ted NMDAR. The enhancement of NMDAR function by specific GLYT1 antagonism m
ay be a feasible target for therapeutic agents directed toward diseases rel
ated to hypofunction of NMDAR.